Yes...very insightful post. The science, or technology, is always the key ingredient in a biotech company. Does the financial picture need to be positive...absolutely! There is no debate regarding that matter. The disagreement on this board is generally when does that picture need to be a crystal clear one. Most here feel it is not yet imperative for all the financials to be resolved for Bioheart to eventually be a success. Time is on our side...we are currently in the lead when it comes to a Phase 3 clinical trial, and doing so with superior results to any and all competitive cellular or device therapies (MyoCell nearly DOUBLES the closest challenger).